doi: 10.1002/jcsm.12775 155 VallianouN
Imagina sentir cmo tu cuerpo trabaja de forma ms eficiente, apoyando tus metas mientras te sientes tranquilo y enfocado
#Pharma #TopSellingDrugs #Biopharma #HealthcareInnovation #Oncology #Immunotherapy #ObesityCare #GLP1 #DrugDevelopment #PharmaceuticalIndustry #MarketInsights #PrecisionMedicine #HealthcareTrends To view or add a comment, sign in More Relevant Posts Top selling drugs of 2025: Oncology (Keytruda, Darzalex and Opdivo) and Metabolic Diseases (Mounjaro, Ozempic, Zepbound and Wegovy) were the dominated sectors : : The pharmaceutical industry in 2025 is being dominated by breakthrough therapies across oncology, metabolic disorders, immunology, and cardiovascular care
At baseline, 220 patients were not receiving diuretics, 223 were receiving non-loop diuretics only, and 702 were receiving loop diuretics
Despite improvements in kidney outcomes with available pharmacotherapies, the risk of kidney failure in people with CKD and T2D remains high [14, 15]